At the same time, in our study BMI had a negligible influence on disease severity (Figure S2A), and biomarkers for liver function such as AST and ALT did not show significant association with disease severity (Figures S3B, C), making nutrition, obesity and liver dysfunction unlikely candidates to explain metabolic changes linearly associated with COVID-19 severity. This evidence concerns the gene GPT and obesity disorder.